Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lp(a)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Not applicableEnrolling By InvitationNCT07177612
What this trial is testing

Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

Who this might be right for
Lipoprotein(a)Lipoprotein(a), Hyper-Lp(a)-Emia
Changi General Hospital 20,000
Testing effectiveness (Phase 2)Study completedNCT05565742
What this trial is testing

LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 320
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableWithdrawnNCT01064934
What this trial is testing

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Who this might be right for
Hyperlipoproteinemia(a)Progressive Cardiovascular Disease
Charite University, Berlin, Germany
Not applicableLooking for participantsNCT06892249
What this trial is testing

Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

Who this might be right for
CKDLow Protein Dietary IntakeMalnutrition (Calorie)
Fresenius Kabi Taiwan Ltd. 80
Large-scale testing (Phase 3)Active Not RecruitingNCT07222384
What this trial is testing

Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 343
Large-scale testing (Phase 3)Ended earlyNCT00562016
What this trial is testing

Protect II, A Prospective, Multicenter Randomized Controlled Trial

Who this might be right for
Coronary Artery Disease
Abiomed Inc. 452
Testing effectiveness (Phase 2)Study completedNCT00596726
What this trial is testing

RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study

Who this might be right for
Cardiac Surgery
Abiomed Inc. 17
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013
What this trial is testing

Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company 17,300
Not applicableActive Not RecruitingNCT06304415
What this trial is testing

Elevated Lipoprotein(a) in Hospital Staff

Who this might be right for
HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaCardiovascular Diseases
Changi General Hospital 2,800
Testing effectiveness (Phase 2)Study completedNCT05563246
What this trial is testing

LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 233
Large-scale testing (Phase 3)Looking for participantsNCT07157774
What this trial is testing

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Who this might be right for
Elevated Lp(a)Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company 10,450
Not applicableNot Yet RecruitingNCT07198009
What this trial is testing

2-HOBA Supplementation in People With Elevated Lipoprotein(a)

Who this might be right for
HyperlipidemiaElevated Lp(a)
The Miriam Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Early research (Phase 1)Looking for participantsNCT06980428
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

Who this might be right for
Healthy ParticipantsDyslipidemia
AstraZeneca 136
Not applicableUnknownNCT05323227
What this trial is testing

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 378
Early research (Phase 1)Active Not RecruitingNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Load More Results